Pyrazinamide is an important pharmaceutical agent primarily used as part of the first-line treatment regimen for tuberculosis (TB). It is a synthetic pyrazine derivative that plays a critical role in shortening the duration of TB therapy. Pyrazinamide is a prodrug and is converted into its active form, pyrazinoic acid, by the bacterial enzyme pyrazinamidase.
